Over the past 12 months, 7 insiders at CERUS CORP filed 25 open-market SEC Form 4 transactions on CERS: 1 purchase worth $31K and 24 sales worth $3.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 16, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 26 | Vivek K JayaramanChief Executive Officer | SELL | 16.7K | $3.16 | $53K |
| Jun 30, 26 | Kevin Dennis GreenChief Financial Officer | SELL | 33.7K | $2.94 | $99K |
| Jun 30, 26 | William Mariner GreenmanPresident and CEO | SELL | 101.9K | $2.94 | $300K |
| Jun 30, 26 | Vivek K JayaramanChief Operating Officer | SELL | 42.4K | $2.94 | $125K |
| Jun 30, 26 | Chrystal JensenChief Legal Officer | SELL | 24.3K | $2.94 | $72K |
| Jun 9, 26 | Eric Bjerkholt | SELL | 20.5K | $2.60 | $53K |
| May 29, 26 | Vivek K JayaramanChief Operating Officer | SELL | 16.7K | $3.00 | $50K |
| May 1, 26 | Vivek K JayaramanChief Operating Officer | SELL | 16.7K | $3.00 | $50K |
| Mar 12, 26 | Richard J BenjaminChief Medical Officer | SELL | 101.7K | $1.66 | $169K |
| Mar 12, 26 | Kevin Dennis GreenChief Financial Officer | SELL | 127.5K | $1.66 | $212K |
| Mar 12, 26 | William Mariner GreenmanPresident and CEO | SELL | 447.8K | $1.66 | $743K |
| Mar 12, 26 | Vivek K JayaramanChief Operating Officer | SELL | 165.2K | $1.66 | $274K |
| Mar 9, 26 | Richard J BenjaminChief Medical Officer | SELL | 40.4K | $1.88 | $76K |
| Mar 6, 26 | Richard J BenjaminChief Medical Officer | SELL | 24.2K | $2.01 | $49K |
| Mar 6, 26 | Kevin Dennis GreenChief Financial Officer | SELL | 27.8K | $2.01 | $56K |
| Mar 6, 26 | William Mariner GreenmanPresident and CEO | SELL | 78.2K | $2.01 | $157K |
| Mar 6, 26 | Vivek K JayaramanChief Operating Officer | SELL | 34.1K | $2.01 | $69K |
| Mar 6, 26 | Chrystal JensenChief Legal Officer | SELL | 30.8K | $2.01 | $62K |
| Mar 5, 26 | Richard J BenjaminChief Medical Officer | SELL | 61.2K | $2.06 | $126K |
| Mar 5, 26 | Kevin Dennis GreenChief Financial Officer | SELL | 55.2K | $2.06 | $114K |
| Nov 24, 25 | Chrystal JensenChief Legal Officer | SELL | 55.0K | $1.70 | $94K |
| Aug 25, 25 | Dean A. GregoryDirector | BUY | 25.0K | $1.25 | $31K |
| Mar 14, 25 | Richard J BenjaminChief Medical Officer | SELL | 30.1K | $1.45 | $44K |
| Mar 14, 25 | Kevin Dennis GreenChief Financial Officer | SELL | 36.7K | $1.45 | $53K |
| Mar 14, 25 | William Mariner GreenmanPresident and CEO | SELL | 122.8K | $1.45 | $178K |
| Mar 14, 25 | Vivek K JayaramanChief Operating Officer | SELL | 46.0K | $1.45 | $67K |
| Mar 14, 25 | Chrystal JensenChief Legal Officer | SELL | 30.1K | $1.45 | $44K |
| Mar 13, 25 | Richard J BenjaminChief Medical Officer | SELL | 18.9K | $1.45 | $27K |
| Mar 13, 25 | Kevin Dennis GreenChief Financial Officer | SELL | 23.1K | $1.45 | $34K |
| Mar 13, 25 | William Mariner GreenmanPresident and CEO | SELL | 71.1K | $1.45 | $103K |
| Mar 13, 25 | Vivek K JayaramanChief Operating Officer | SELL | 30.0K | $1.45 | $43K |
| Mar 13, 25 | Chrystal JensenChief Legal Officer | SELL | 18.9K | $1.45 | $27K |
| Mar 12, 25 | Chrystal JensenChief Legal Officer | SELL | 113.0K | $1.66 | $188K |
| Mar 7, 25 | Richard J BenjaminChief Medical Officer | SELL | 26.1K | $1.50 | $39K |
| Mar 7, 25 | Kevin Dennis GreenChief Financial Officer | SELL | 31.1K | $1.50 | $47K |
| Mar 7, 25 | William Mariner GreenmanPresident and CEO | SELL | 61.0K | $1.50 | $91K |
| Mar 7, 25 | Vivek K JayaramanChief Operating Officer | SELL | 34.0K | $1.50 | $51K |
| Mar 7, 25 | Chrystal JensenChief Legal Officer | SELL | 27.5K | $1.50 | $41K |
| Mar 4, 25 | Richard J BenjaminChief Medical Officer | SELL | 6.3K | $1.55 | $10K |
| Mar 4, 25 | Kevin Dennis GreenChief Financial Officer | SELL | 8.4K | $1.55 | $13K |
| Mar 4, 25 | William Mariner GreenmanPresident and CEO | SELL | 23.0K | $1.55 | $36K |
| Mar 4, 25 | Vivek K JayaramanChief Operating Officer | SELL | 10.8K | $1.55 | $17K |
| Mar 4, 25 | Chrystal JensenChief Legal Officer | SELL | 60.0K | $1.59 | $95K |
| Mar 3, 25 | Richard J BenjaminChief Medical Officer | SELL | 51.3K | $1.58 | $81K |
| Mar 3, 25 | Kevin Dennis GreenChief Financial Officer | SELL | 60.7K | $1.58 | $96K |
| Dec 16, 24 | Chrystal JensenChief Legal Officer | SELL | 16.7K | $1.71 | $29K |
| Dec 13, 24 | Dean A. GregoryDirector | BUY | 1.7K | $1.70 | $3K |
| Dec 12, 24 | Eric BjerkholtDirector | SELL | 20.0K | $1.79 | $36K |
| Sep 4, 24 | Kevin Dennis GreenChief Financial Officer | SELL | 54.3K | $2.15 | $117K |
| Sep 3, 24 | Kevin Dennis GreenChief Financial Officer | SELL | 28.4K | $2.18 | $62K |
Over the past 12 months, insiders at CERUS CORP filed 1 open-market purchase worth $31K and 24 sales worth $3.3M on CERS, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 16, 26.
The largest recent open-market CERS insider purchase in our data was $31K by Dean A. Gregory, Director, filed on Aug 25, 25.
7 different insiders at CERUS CORP filed open-market SEC Form 4 transactions on CERS over the last 12 months.
InsiderTape plots every CERS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every CERUS CORP insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →